Phil brings several years of clinical research experience in oncology and radiology to his work supporting clients at LifeSci. His background in clinical drug development guides his strategic recommendations and commercial assessments.
His work includes commercial due diligence and valuation, with a specialization in oncology. Prior to joining LifeSci, Phil worked at Memorial Sloan Kettering Cancer Center supporting early-stage clinical research related to the development of radiotherapies and novel imaging agents.
BS., Biological Sciences, Cornell University